In-depth analysis across multiple industries. Data-driven insights to guide your strategic decisions.
Industry Coverage
Pharmaceuticals, biotechnology, drug delivery systems, and healthcare IT intelligence.
45,070 published reports
In Europe, Middle East and Africa, The main manufacturers are Sterimar, Laboratoire DE LA Mer, Gerolymatos International, Humer (Laboratoire Urgo), Gifrer, GSK, Nacur Healthcare, L...
The global Targeting Small Molecule Tumor Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the...
The global Adefovir Dipivoxil Tablet market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over...
The global Fluticasone Nasal Sprays market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over...
The global MSM Placebo market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032. The US & Canada market for MSM Placebo is p...
The global Repurposed Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032. The US & Canada market fo...
The global Beta-2 Microglobulin (B2M) market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032. The US & Canada market for B...
The global Serotonin-Norepinephrine Inhibitor market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032. The North...
The global Anti-diabetic Medication market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032. North America: the...
The global Hepatitis B Therapeutic Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032. The US & Cana...
The global OTC Pain Medicines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032. The US & Canada market...
The global Somatostatin and Somatostatin Analogs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032. The...
According to APO Research, the global Preterm Birth Prevention and Management market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAG...
The global Hyoscyamine Sulfate Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032. The North Am...
The global Artesunate Medicines market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032. North America: the Arte...
The global PD-L1 Inhibitors market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-203...
The global Glucose Excipient market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032. The North America market...
The global B Cell Receptor Inhibitor market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032. The North America...
The global Sarcopenia Supplement market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast perio...
The global Nuclear Drug for Therapeutic market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % o...
